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Introduction
Ischemic stroke is a substantial public health problem.
Indeed, it is the third leading cause of death, after heart
disease and cancer, and the leading cause of long-term
disability in major industrialized countries (1). A widely
applicable treatment for cerebral ischemia would therefore
have an enormous impact on public health: however, no such
beneficial treatment has yet been found (2,3). Clinical and
experimental data suggest that ischemic neuronal damage is
at least partly induced by the free radicals and/or lipid
peroxidation produced either during the ischemia itself or
following reperfusion (4–6).
Propolis (honeybee glue), a resinous product consisting of
sap, bark and bee excreta, accumulates in bee hives. It is cur-
rently used as a health food and for the treatment of various
ailments. Indeed, it has been shown to have a wide range of
biological activities, principally attributable to the presence of
flavonoids (major component; rutin, quercetin, galangin, etc.)
(7) and caffeic acid phenethyl ester (CAPE) (8). Hence, the
putative therapeutic properties of propolis could be related to
its antibacterial (9,10), anti-inflammatory (11), antioxidative
(12,13) and/or tumoricidal (14,15) activities.
In total, at least 200 compounds have been identified in
different samples of propolis, with  100 being present in any
given sample. These include: fatty and phenolic acids and esters,
substituted phenolic esters, flavonoids (flavones, flavanones,
flavonols, dihydroflavonols, chalcones), terpenes,  -steroids,
aromatic aldehydes and alcohols, and derivatives of sesquiter-
penes, naphthalene and stilbenes (16–19). Propolis has a variety
of botanical origins, and its chemical composition can also be
variable. Baccharis dracunculifolia DC (Asteraceae), a native
plant from Brazil, is the most important botanical source of
Southeastern Brazilian propolis, known as green propolis
because of its color (20–24). In recent years, green propolis
has been widely studied because of its characteristic chemical
composition and biological activities (25). In Japan in particu-
lar, Brazilian propolis is used extensively in foods and bever-
ages with the aim of maintaining or improving human health
(16,19). However, to our knowledge, no examination of the
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To examine the function of Brazilian green propolis on
neuronal damage in vivo and in vitro, we used, respectively:
a middle cerebral artery (MCA) occlusion model in mice, and
hydrogen peroxide (H2O2)- and serum deprivation-induced
neurotoxicity in PC12 cells. In addition, we examined the
effects of propolis (i) on lipid peroxidation in the mouse brain;
and (ii) against diphenyl-p-picrylhydrazyl (DPPH)-induced
free radicals.
Methods
Materials
Drugs and sources were as follows: Dulbecco’s modified
Eagle’s medium (DMEM), DPPH, 2-thiobarbituric acid, 2,3,5-
triphenyltetrazolium chloride (TTC), resazurin and Trolox
(a derivative of  -tocopherol) were purchased from Sigma-
Aldrich (St Louis, MO). Fetal bovine serum (FBS) and horse
serum were from VALEANT (Costa Mesa, CA) and Sanko
Junyaku (Tokyo, Japan), respectively. Collagen type IV was
from Koken (Tokyo, Japan). Bovine serum albumin (BSA)
was from Nacalai (Kyoto, Japan). H2O2 was from Wako
(Osaka, Japan). Nerve growth factor (NGF), which was puri-
fied from male mouse submaxillary glands, was donated by
Dr Shoei Furukawa (26), and isoflurane came from Nissan
Kagaku (Tokyo, Japan). Brazilian green propolis (Brazil,
Minas Gerais state) was extracted either with 95% ethanol at
room temperature or with water at 50 C to yield the extract
used. The plant of origin for Brazilian green propolis was
B. dracunculifolia (21). The water extract was used in both
in vitro and in vivo studies, while the ethanol extract was used
only in the in vitro study. Hoechst 33342 and propidium iodide
(PI) were from Molecular Probes (Eugene, OR).
Cell Culture
PC12 cells were maintained in DMEM supplemented with
10% heat-inactivated horse serum and 5% heat-inactivated
FBS. Cultures were maintained at 37 C in a humidified 5%
CO2 atmosphere.
To examine the effect of propolis on 0.2 mM H2O2-induced
cell death, cells were seeded at a density of 2   104 cells per
well into collagen-coated 24-well plates, prepared by putting
hydrochloric acid solution (pH 3.0) containing 30 mg/ml
collagen into the wells, and left for 2 h. After incubating the
cells for 1 day, they were differentiated into neuronal cells by
adding 20 ng/ml NGF to the above medium for 3 days. To
induce cell death, the differentiated cells were immersed in
serum-free DMEM supplemented with 0.1% BSA. After pre-
treatment with propolis or Trolox for 30 min, H2O2 was added
to PC12 cell cultures for 24 h.
To examine how propolis acted on serum deprivation-induced
cell death, cells were seeded into collagen-coated 24-well plates
at a density of 1   104 cells per well. After incubating for 1 day,
cells were differentiated into neuronal cells as described above.
To induce cell death, the differentiated cells were immersed in
serum-free DMEM supplemented with 0.1% BSA, and main-
tained in this condition for 2 days.
Cell Viability
To evaluate cell survival, we examined the change in fluores-
cence intensity following cellular reduction of resazurin to
resorufin. All experiments were performed in DMEM at 37 C.
Cell viability was assessed following immersion in 10%
resazurin solution for 3 h at 37 C, and fluorescence was
recorded at 560/590 nm.
Hoechst 33342 and PI Dual Staining
At the end of the cell culture, we added Hoechst 33342 ( ex
350 nm,  em 461 nm) and PI ( ex 535 nm,  em 617 nm) to
the culture medium for 15 min at final concentrations of 8.1
and 1.5  M, respectively. The viable cells were Hoechst
33342-positive and PI-negative, whereas dead cells were both
Hoechst 33342-positive and PI-positive.
DPPH-induced Free Radicals
Free radical-scavenging activity was determined by the
method of Mellors and Tappel (27), adding 0.25 ml of the drug
dissolved in ethanol to 1.5 ml of ethanolic DPPH. The result-
ing decrease in DPPH absorption at 517 nm was measured
after 30 min.
Lipid Peroxidation in Mouse Forebrain Homogenate
The supernatant fraction of mouse forebrain homogenate of
male adult ddY mice, weighing 20–25 g (Japan SLC, Shizuoka,
Japan), was prepared as described elsewhere (28). Brain
tissues were homogenized in a glass–Teflon homogenizer in
4 vols of ice-cold phosphate saline buffer (50 mM, pH 7.4), and
the homogenate was stored at  80 C. The stock brain
homogenate was diluted 10-fold with the same buffer, then
2 ml portions of the diluted homogenate were added to 10  l
of the test compound and incubated at 37 C for 30 min. The
reaction was stopped by adding 400  l of 35% HClO4, fol-
lowed by centrifugation at 2800 r.p.m. for 10 min. The super-
natant (1 ml) was heated with 0.5 ml of thiobarbituric acid
(TBA) solution (5 g/l in 50% acetic acid) for 15 min at 100 C.
Absorbance was then measured at 532 nm.
Focal Cerebral Ischemia Model in Mice
Male adult ddY mice, weighing 20–27 g (Japan SLC), were
kept under diurnal lighting conditions. Anesthesia was
induced by 2.0% isoflurane and maintained with 1% isoflu-
rane in 70% N2O and 30% O2 using an animal general anes-
thesia machine (Soft Lander; Sin-ei Industry Co. Ltd,
Saitama, Japan), maintaining body temperature between 37.0
and 37.5 C with the aid of a heating pad and heating lump.
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described previously (29). Briefly, the left MCA was occluded
using an 8–0 nylon monofilament (Ethicon, Somerville, NJ)
coated with a mixture of silicone resin (Xantopren; Bayer
Dental, Osaka, Japan). Twenty-four hours after this occlusion,
the forebrain was divided into five coronal (2 mm) sections
using a mouse brain matrix (RBM-2000C; Activational
Systems, Warren, MI), and the sections were stained with 2%
TTC. All images of the infarcted areas were saved using a
digital camera (Nikon Cool PIX4500) and quantitated using
NIH Image software, calculations being performed as in our
previous report (29). Brain swelling was calculated according
to the following formula: (infarct volume   ipsilateral undam-
aged volume   contralateral volume)   100/contralateral
volume (%) (29).
Mice were tested for neurological deficits at 24 h after the
occlusion, scoring being as described in our previous report
(29): 0, no observable neurological deficits (normal); 1, fail-
ure to extend right forepaw (mild); 2, circling to the con-
tralateral side (moderate); 3, loss of walking or righting
reflex (severe). The person doing the scoring was naïve to the
treatment group.
Propolis, extracted with water, was administered intraperi-
toneally (i.p.) at doses of 30 or 100 mg/kg (0.1 ml/10 g) four
times (at 2 days, 1 day and 60 min before, and at 4 h after the
occlusion). Propolis was dissolved in purified water and made
fresh daily.
Statistical Analysis
Data are presented as the mean   SEM. Statistical compar-
isons were made by means of a one- or two-way analysis of
variance (ANOVA) followed by a Student’s t-test, Dunnett’s
test or Mann–Whitney U-test using STAT VIEW, version 5.0
(SAS Institute Inc., Cary, NC). A P   0.05 was considered
statistically significant.
Results
Propolis Inhibited H2O2- or Serum Deprivation-
induced Cell Damage in PC12 Cell Culture
Propolis, extracted with ethanol, significantly inhibited both
H2O2- and serum deprivation-induced cell death in PC12 cell
culture at concentrations of 4 and 40  g/ml (Tables 1 and 2).
At 4  g/ml, propolis extracted with water inhibited the serum
deprivation-induced cell death as successfully as propolis
extracted with ethanol.
Trolox at 10  M (Table 1) and NGF at 1 and 10 ng/ml
(Table 2) inhibited the cell death induced by H2O2 or serum
deprivation, respectively.
Figure 1 shows typical photographs of Hoechst 33342 and
PI staining. Hoechst 33342 stained all cells (live and dead),
while PI stained only dead cells. Propolis (4  g/ml) decreased
the number of cells showing PI staining following serum
deprivation (versus vehicle treatment).
Propolis Reduced DPPH-induced Free Radicals and
Lipid Peroxidation in Mouse Forebrain Homogenate
An inducer of stable free radicals, DPPH, was used to assess
the radical-scavenging activities of propolis, which was
extracted with ethanol, and Trolox (a derivative of  -tocopherol;
vitamin E). Propolis and Trolox each reduced DPPH-induced
free radical activity in a concentration-dependent manner,
reaching significant levels at 2  g/ml or more and 0.2  M or
more, respectively. The IC50 values [the concentrations causing
50% inhibition, with 95% confidence limits (in parentheses)]
for propolis and Trolox were 4.2 (2.0–11.7)  g/ml and 1.4
(0.7–3.1)  M, respectively.
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Table 1. Propolis and Trolox inhibited H2O2-induced neurotoxicity in
PC12 cell cultures
Treatments Cell viability (% of no treatment)
No treatment 100   6.3#
Control 77   3.3
Propolis 0.4  g/ml 83   4.6
Propolis 4  g/ml 108   6.3#
Propolis 40  g/ml 110   6.2#
Trolox 10  M8 8   4.7*
Differentiated PC12 cells were immersed in serum-free DMEM
supplemented with 0.1% BSA. After pre-treatment with propolis (extract with
ethanol) or Trolox for 30 min, 0.2 mM H2O2 was added to the cell cultures
for 24 h. Cell viability was assessed by adding 10% resazurin solution for 3 h
at 37 C, and fluorescence was recorded at 560/590 nm. Values represent the
mean   SEM of six independent experiments. *P   0.05, #P   0.01 versus
control (H2O2 alone).
Table 2. Propolis and NGF inhibited serum deprivation-induced
neurotoxicity in PC12 cell cultures
Treatments Cell viability (% of no treatment)
No treatment 100   3.7#
Control 44   1.7
Propolis 0.4  g/mla 46   2.4
Propolis 4  g/ml 52   2.1*
Propolis 40  g/ml 50   2.0*
Propolis 4  g/mlb 53   2.1*
No treatment 100   9.3#
Control 40   2.3
NGF 0.1 ng/ml 52   4.1
NGF 1 ng/ml 74   3.8#
NGF 10 ng/ml 83   8.3#
Differentiated PC12 cells were immersed in serum-free DMEM
supplemented with 0.1% BSA, and then propolis or NGF was added to the
cell cultures. Cells were maintained in this condition for 2 days. Cell viability
was assessed by adding 10% resazurin solution for 3 h at 37 C, and
fluorescence was recorded at 560/590 nm.
aExtract with ethanol.
bExtract with water.
Values represent the mean   SEM of five independent experiments.
*P   0.05, #P   0.01 versus the respective control (serum deprivation 
alone).In the lipid peroxidation study, the malondialdehyde (MDA)
level in the supernatant increased after 30 min incubation at 
37 C, and propolis (extract with both ethanol and water) and
Trolox inhibited the lipid peroxidation in a concentration-
dependent manner (Fig. 2). The IC50 values (95% confidence
limits) for propolis (extract with ethanol), propolis (extract
with water) and Trolox were 1.4 (0.97–2.2)  g/ml, 0.76
(0.52–1.1)  g/ml and 16.8 (10.4–28.8)  M, respectively.
Propolis Reduced Infarction, Brain Swelling and
Neurological Deficits Induced by MCA Occlusion in Mice
Animals treated with propolis at 30 or 100 mg/kg, i.p. showed
no behavioral changes other than the neurological deficits
induced by ischemia. Twenty-four hours after MCA occlusion,
mice developed infarcts affecting both cortex and striatum
(Fig. 3, left side). In this study, we used propolis extracted with
water, because ethanol itself might influence behavior.
Propolis (30 mg/kg) reduced the infarct area at the level of
coronal slice 10 mm (‘0 mm’ being the rostral tip of the fore-
brain) (Fig. 4). At 100 mg/kg, propolis reduced the infarct
areas at the levels of coronal slices 6, 8 and 10 mm, and also
infarct volume and brain swelling (Fig. 3, right side, and
Fig. 4). Brain swelling (see Materials and Methods) at 24 h
after the occlusion was 41.9   4.9% (mean   SEM, n   11),
32.3   3.9% (n   12) and 23.4   4.5% (n   12) following
treatment with vehicle, propolis 30 mg/kg and propolis
100 mg/kg, respectively (the effect of propolis 100 mg/kg
being significant versus vehicle).
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Figure 1. Typical photographs illustrating the effect of propolis on serum deprivation-induced cell damage in PC12 cell cultures [Hoechst 33342 and propidium
iodide (PI) single or dual staining]. Differentiated PC12 cells were immersed in serum-free DMEM supplemented with 0.1% BSA, and then propolis was added
to the cell cultures. Cells were maintained in this condition for 2 days. Viable cells are Hoechst 33342-positive and PI-negative, whereas dead cells are Hoechst
33342-positive and PI-positive. At 4  g/ml, propolis (extract with ethanol) decreased the number of cells stained by PI (versus vehicle treatment). (A, D and H)
Control (vehicle treatment). (B, E and I) Vehicle treatment   serum deprivation. (C, F and J) Propolis treatment   serum deprivation. (A–C) Hoechst 33342
staining. (D–F) PI staining. (G–I) Merged images (Hoechst 33342   PI dual staining).At 30 min after the occlusion, both vehicle- and propolis-
treated mice displayed moderate neurological deficits (circling,
decreases in resistance to lateral push and locomotor activity,
flexion of contralateral torso, and forelimb upon lifting the
animal by its tail and abnormal posture). Animals that did not
show neurological deficits at this point were excluded from the
study on the grounds that the MCA was not occluded success-
fully. The mean scores allocated for neurological deficits in the
vehicle-, propolis 30 mg/kg- and propolis 100 mg/kg-treated
groups were 1.45   0.16 (n   11), 1.33   0.19 (n   12) and
1.17   0.11 (n   12), respectively. Although the high dose of
propolis tended to reduce the neurological deficits, statistical
significance was not attained.
Discussion
Here, we compared the effects of propolis with those of Trolox
or NGF (i) against H2O2- and serum deprivation-induced cell
damage in neuronally differentiated PC12 cell cultures; and
(ii) against lipid peroxidation in the mouse forebrain and
DPPH-induced free radical production. Furthermore, we
examined the function of propolis on the neuronal damage
seen after permanent MCA occlusion in mice. Our results
indicate that propolis inhibits neuronal damage both in vitro
and in vivo.
Reactive oxygen species (ROS) such as H2O2, nitric oxide
(NO), superoxide anion (O·2
 ) and hydroxyl radical (·OH) have
been implicated in the regulation of many important cellular
events, including transcription factor activation (30), gene expres-
sion (31) and cellular proliferation (32). However, excessive
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Figure 2. Propolis and Trolox reduced (A) DPPH-induced free radicals and
(B) lipid peroxidation in mouse forebrain homogenate. DPPH, diphenyl-p-
picrylhydrazyl; TBARS, thiobarbituric acid-reactive substance. Values repre-
sent the mean   SEM of 4–8 independent experiments. 1extract with ethanol;
2extract with water. *P   0.05;  #P   0.01 versus control (vehicle-treated
group).
Figure 3. 2,3,5-Triphenyltetrazolium chloride (TTC) staining of coronal brain
sections (thickness, 2 mm) from representative mice at 24 h after permanent
middle cerebral artery (MCA) occlusion. Damaged tissue shows as white areas.
Sections are arranged from rostral (top) to caudal (bottom). Left and right sec-
tions are from vehicle-injected mouse (control) and propolis-treated mouse,
respectively. Propolis (extract with water, 100 mg/kg) was administered i.p. four
times (at 2 days, 1 day and 60 min before, and at 4 h after the occlusion).
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Figure 4. (A) Propolis reduced the brain infarct area at 24 h after permanent
middle cerebral artery (MCA) occlusion in mice. The brains were removed
and the forebrains sliced into five coronal 2 mm sections. Propolis, which was
extracted with water, was administered i.p. at 30 or 100 mg/kg four times (at
2 days, 1 day and 60 min before, and at 4 h after the occlusion). Infarct areas
were revealed by 2% 2,3,5-triphenyltetrazolium chloride (TTC) staining.
Values represent the mean   SEM of 11 or 12 independent experiments.
*P   0.05, #P   0.01 versus control (vehicle treatment). (B) Propolis reduced
the infarct volume at 24 h after permanent MCA occlusion in mice. Values
represent the mean   SEM of 11 or 12 independent experiments. #P   0.01
versus control (vehicle treatment).production of ROS gives rise to events that lead to death in
several types of cells (33). In fact, ROS have induced death
in vitro among cultured neurons (34) and cultured PC12 cells
(35). In our experiments, low concentrations ( 0.1 mM) of
H2O2 induced cellular proliferation, and consequently cell via-
bility was increased. In contrast, high concentrations ( 0.2
mM) induced cell death in a concentration-dependent manner
(data not shown). Therefore, we used 0.2 mM hydrogen perox-
ide in this study. It is known that cells possess antioxidant sys-
tems to control the redox state, which is important for their
survival, and H2O2 is often used to investigate the mechanism
underlying ROS-induced cell death (36,37).
We found that propolis at concentrations of 4 and 40  g/ml
inhibited H2O2- and serum deprivation-induced cell death in
neuronal PC12 cell cultures. Thus, propolis was a more potent
inhibitor of H2O2-induced cell death than serum deprivation-
induced cell death. Furthermore, propolis acted against oxida-
tive stress (lipid peroxidation) in mouse forebrain homogenates
and exhibited a free radical-scavenging action (as assessed
using DPPH). The potencies of propolis (extract with both
ethanol and water) on lipid peroxidation were almost the same,
with effective concentrations of propolis ranging from 2 to
40  g/ml. Propolis has been reported to exhibit strong
scavenging activity in vitro towards both the superoxide anion
radical and the NO radical (38). Collectively, these find-
ings indicate that the antioxidant function of propolis may
contribute to its neuroprotective potential.
Such an antioxidant function may be an underlying mecha-
nism by which propolis protects against neuronal damage
(infarction and swelling) after focal ischemia. Excessive
production of ROS is believed to play a critical role in the
development of ischemic brain injury (5,39). In fact, ROS may
contribute to brain injury directly (by attacking such macro-
molecules as proteins, lipids and DNA) and/or indirectly (by
affecting cellular signaling pathways and gene regulation)
(40–42). We evaluated the potential benefit of  -tocopherol in
cerebral ischemia some years ago (43). Furthermore, edar-
avone (3-methyl-1-phenyl-2-pyrazolin-5-one), an antioxida-
tive radical scavenger, was recently approved for the treatment
of acute cerebral infarction in Japan (44). When propolis (30
or 100 mg/kg, i.p.) was administered four times in our cerebral
ischemia experiment, it reduced infarction size at 24 h after the
MCA occlusion. Recently, CAPE—which is an active compo-
nent of propolis extracts and exhibits antioxidant properties—
has been reported to reduce the neuronal damage induced by
transient forebrain ischemia (45), myocardial ischemia (46)
and spinal cord ischemia (47). These CAPE studies indicate
that the protective function of propolis may stem from the
antioxidant properties of CAPE.
Although CAPE is Poplar type propolis, Brazilian green
propolis is Baccharis type—which contains various compounds
(21). In a recent study, we showed that ethanol and water
extracts of Brazilian green propolis contain artepillin C (14.0%),
baccharin (6.8%), 3,4-di-O-caffeoylquinic acid (3.5%), 3,5-di-
O-caffeoylquinic acid (2.7%) and p-coumaric acid (2.5%), and
3,4-di-O-caffeoylquinic acid (6.1%), 3,5-di-O-caffeoylquinic
acid (4.9%), p-coumaric acid (3.7%) and chlorogenic acid
(3.6%), respectively (48). In the present study, since both
propolis extracts exhibited a neuroprotective function against
in vitro cell death and in vivo ischemia-induced neuronal dam-
age, the common constituents (such as 3,4-di-O-caffeoylquinic
acid, 3,5-di-O-caffeoylquinic acid and p-coumaric acid) may
be responsible.
Propolis reportedly has anti-inflammatory activity (11). There
is substantial evidence that inflammation, such as neutrophil
infiltration and release of interleukin-1 and tumor necrosis
factor-  (TNF ), contributes to secondary brain injury after
ischemia and reperfusion (49), and that pharmacological 
anti-inflammatory treatments are beneficial in focal ischemia
models (50). Hence, we cannot exclude the possibility that the
neuroprotection of propolis against focal ischemia-induced
neuronal damage may depend to some extent on its anti-
inflammatory activity.
In conclusion, in vitro propolis was neuroprotective in PC12
cell culture, and acted as an antioxidant against lipid peroxida-
tion and free radical production. Furthermore, in vivo, propolis
was neuroprotective against ischemic injury (cerebral infarc-
tion and swelling in mice). These findings are consistent with
the observation that the anti-ischemic function of propolis
derives, at least in part, from its antioxidant properties.
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